Skip to main content
. 2021 Aug 16;11(8):e044724. doi: 10.1136/bmjopen-2020-044724

Table 1.

Demographic and clinical details of the sample

Characteristic People with MND (n=25) Caregivers (n=10)
Age (range 39–80)
 35–50 years 3 0
 51–65 years 12 4
 66–80 years 10 6
Gender
 Male 15 5
 Female 10 5
Relationship to person with MND
 Spouse/partner 10
Diagnosis
 ALS limb 18
 ALS bulbar 1
 Primary lateral sclerosis 4
 Progressive bulbar palsy 1
 Progressive muscular atrophy 1
Time since diagnosis (range 2 months to 17 years)
 Less than 1 year 8
 1–3 years 6
 3–5 years 7
 More than 5 years 4
Difficulties reported often/always* (ALSAQ-5 scale)
 Difficult to stand up 16
 Difficult to use arms and hands 16
 Difficulty eating solid food 4
 Speech is not easy to understand 9
 Feeling hopeless about the future 3
Self-reported concerns about cognitive ability 2

*ALSAQ-5 is a patient self-report questionnaire used to briefly measure the impact of ALS/MND on patients.51

ALS, Amyotrophic Lateral Sclerosis; ALSAQ-5, Amyotrophic Lateral Sclerosis Assessment Questionnaire 5; MND, motor neuron disease.